natgillin/translations-raw huggingface dataset:
Tablete po 150 mg in 300 mg: 4 leta Tablete po 30 mg in 900 mg: 3 leta 
150mg and 300mg tablets: 4 years 30mg and 900mg tablets: 3 years 6.4 Special precautions for storage Do not store above 25°C.
Ibafloksacin 30 mg Ibafloksacin 150 mg Ibafloksacin 300 mg Ibafloksacin 900 mg 
Ibaflin 30 mg: ibafloxacin 30 mg Ibaflin 150 mg: ibafloxacin 150 mg Ibaflin 300 mg: ibafloxacin 300 mg Ibaflin 900 mg: ibafloxacin 900 mg
4.9 Odmerjanje in pot uporabe 
4.9 Posology and method of administration
MIK ibafloksacina (matične spojine) so v razponu 0,032 do 0,5 µg/ml za E. coli, Staphylococcus spp. 
For ibafloxacin (parent compound), MIC values ranging from 0.032 - 0.5 µg/ml are observed for canine isolates of E. coli, Staphylococcus spp.
Varnost zdravila ni raziskana pri psicah v obdobju laktacije in pri brejih mačkah in mačkah v obdobju laktacije. 
The safety of the veterinary medicinal product has not been established in lactating dogs and in pregnant and lactating cats.
in Proteus mirabilis v vzorcih, izoliranih pri psih. 
and Proteus mirabilis.
Zdravila ne uporabljajte v obdobju rasti ali v kombinaciji z nesteroidnimi protivnetnimi zdravili (NSAID) pri psih, ki imajo v anamnezi krče. 
Do not use during the period of growth or in combination with nonsteroidal anti-inflammatory drugs (NSAIDs) in dogs with a history of seizures.
Z 1 BRIZGO IBAFLIN 7,5 % PERORALNEGA GELA / ZLOŽENKA S 5 BRIZGAMI IBAFLIN 7,5 % PERORALNEGA GELA 
CARTON BOX FOR 1 SYRINGE IBAFLIN 7.5% ORAL GEL / CARTON BOX FOR 5 SYRINGES IBAFLIN 7.5% ORAL GEL
ZDRAVILA Peroralno, 15 mg ibafloksacina/kg 1-krat na dan. 
Oral use, 15 mg ibafloxacin/kg once daily.
Pri psih doseže največjo raven v plazmi v 2 urah pri dajanju 
In dogs the maximum plasma levels were observed at 2 hours when administered with or without food.
Varnost zdravila ni raziskana med laktacijo. 
The safety of the veterinary medicinal product has not been established during lactation.
Ibaflin 7,5 %, peroralni gel: 75 mg ibafloksacina v 1 g gela (ustreza 78,8 mg/ml) Pomožne snovi 
STATEMENT OF THE ACTIVE AND OTHER SUBSTANCE(S) Ibaflin 7.5% Oral Gel: 75 mg of ibafloxacin per g of gel (equivalent to 78.8 mg/ml) Excipients
Ibafloksacin je širokospektralen, baktericidni antibiotik iz skupine kinolonov. 
Ibafloxacin is a broad spectrum bactericidal antibiotic from the quinolone group.
Varnost zdravila ni raziskana pri brejih mačkah ter pri psicah in mačkah v obdobju laktacije. 
The safety of the veterinary medicinal product has not been established in pregnant cats and in lactating dogs and cats.
trženja za zdravilo, odobreno 
MARKETING AUTHORISATION HOLDER
s pomikom objemke na ustrezno mesto na batu (brizga s 30 ml - stopnje po 1,0 ml). 
The syringe should be adjusted to the calculated dosage by setting the ring on the appropriate place on the plunger (steps of 0.5 ml for the 15 ml syringe and 1.0 ml for the 30 ml syringe).
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Ibaflin 3 %, peroralni gel za pse in mačke 
NAME OF THE VETERINARY MEDICINAL PRODUCT Ibaflin 3% oral gel for dogs and cats
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Ibaflin 3 %, peroralni gel 
NAME OF THE VETERINARY MEDICINAL PRODUCT Ibaflin 3% oral gel
Ibaflin 3 %, peroralni gel: 30 mg ibafloksacina v 1 g gela (ustreza 30,9 mg/ml) Pomožne snovi 
STATEMENT OF THE ACTIVE AND OTHER SUBSTANCE(S) Ibaflin 3% Oral Gel: 30 mg of ibafloxacin per g of gel (equivalent to 30.9 mg/ml); Excipients
0,5 ml gela na kg telesne mase 
0.5 ml of gel per kg body weight
Farmakokinetični podatki 
Pharmacokinetic particulars
Osebe z znano preobčutljivostjo za kinolone se morajo izogibati stiku z izdelkom. 
Persons with known hypersensitivity to quinolones should avoid contact with the product.
Na veterinarski recept. 
Veterinary medicinal product subject to prescription.
Številka dovoljenja za promet EU/2/00/022/09-12 
Marketing Authorisation number(s) EU/2/00/022/09-12
Shranjujte nedosegljivo otrokom. 
Keep out of the reach and sight of children.
Končna razpolovna doba izločanja iz plazme je približno 4 do 5 ur. Izloča se pretežno z urinom 
Terminal plasma halflife is approximately 4-5 hours.
Kinolonov ne smemo uporabljati v kombinaciji z nesteroidnimi protivnetnimi zdravili (NSAID) pri psih, ki imajo v anamnezi konvulzije. 
Quinolones should not be used in combination with nonsteroidal anti-inflammatory drugs (NSAID) in dogs with a history of seizures.
Varnost zdravila ni raziskana pri psicah v obdobju laktacije. 
The safety of the veterinary medicinal product has not been established in lactating dog.
ZDRAVILA ALI ODPADNIH SNOVI, ČE OBSTAJAJO 
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIAL, IF ANY
Bela, nastavljiva večodmerna napolnjena brizga iz polietilena visoke gostote (HDPE, telo, bat in objemka) 
White adjustable multidose pre-filled syringe consisting of high density polyethylene (HDPE, barrel, plunger and ring) and low density polyethylene (LDPE, cap and seal).
Z ZDRAVILOM TER OMEJITVE GLEDE OSKRBE IN UPORABE 
RESTRICTIONS REGARDING SUPPLY AND USE Veterinary medicinal product subject to prescription.
DODATEK III 
B. PACKAGE INSERT
in Salmonella spp., izolirane pri psih. 
and Salmonella spp.
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Ibaflin 7,5 %, peroralni gel za pse 
NAME OF THE VETERINARY MEDICINAL PRODUCT Ibaflin 7.5% oral gel for dogs
Številke dovoljenja za promet EU/2/00/022/001-008 
Marketing Authorisation number(s) EU/2/00/022/001-008
in Klebsiella spp. (MIK ≤ 0,5 µg/ml ibafloksacina). 
(MIC ≤ 0.5 µg ibafloxacin/ml).
Ibaflin je pri psih indiciran za zdravljenje naslednjih bolezenskih stanj: 
Ibaflin is indicated for the treatment of the following conditions in dogs:
ibafloksacina (matične spojine) so v razponu 0,032 do 0,5 µg/ml za E. coli, Staphylococcus spp., 
For ibafloxacin (parent compound), MIC values ranging from 0.032 - 0.5 µg/ml are observed for canine isolates of E. coli, Staphylococcus spp., Proteus mirabilis, strains of Pasteurella spp.
Ibaflin gel je pri mačkah indiciran za zdravljenje naslednjih bolezenskih stanj: 
Ibaflin gel is indicated in cats for treatment of the following conditions:
Pri večini pasem je uporaba ibafloksacina kontraindicirana za pse, mlajše od 8 mesecev, pri zelo velikih pasmah pa za pse, mlajše od 18 mesecev. 
For the majority of breeds the use of ibafloxacin is contra-indicated in dogs less than 8 months of age and in giant breeds less than 18 months.
ŠTEVILKA(E) DOVOLJENJ(A) 
Active substance(s)
Ibaflin smemo uporabljati samo na podlagi testiranja občutljivosti povzročitelja. 
Ibaflin should only be used based on susceptibility testing.
Ibaflin gel smemo uporabljati samo na podlagi testiranja občutljivosti povzročitelja. 
Ibaflin gel should only be used based on susceptibility testing.
Ibafloksacin 
Cellulose
NAVEDBA ZDRAVILNE UČINKOVINE IN DRUGIH SESTAVIN 
STATEMENT OF ACTIVE AND OTHER SUBSTANCES Ibafloxacin
ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROSTITEV SERIJE 
A. MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
Končna razpolovna doba izločanja iz plazme je približno 3 do 5 ur. Skupna absorpcija je bila večja, kadar 
Terminal plasma halflife is approximately 3-5 hours.
Farmakodinamične lastnosti 
Pharmacodynamic properties
sklepnega hrustanca pri mačkah v obdobju hitre rasti ni podatkov. 
No information is available on the influence of ibafloxacin on developing articular cartilage in the cat during the period of rapid growth as articular cartilage may be affected.
in doseže največjo raven v plazmi v 1 uri, kadar ga dajemo brez hrane, in v 2 urah, kadar ga dajemo s hrano. 
After oral administration in cats, ibafloxacin is rapidly absorbed with maximum plasma levels observed at 1 hour when administered without food and 2 hours when administered with food.
INDIKACIJE Ibaflin gel je pri psih indiciran za zdravljenje naslednjih bolezenskih stanj: - dermalne okužbe (pioderma - površinska in globoka, rane, abscesi), ki jih povzročajo občutljivi mikroorganizmi, kot so Staphylococcus spp., E. coli in Proteus mirabilis 
INDICATIONS Ibaflin gel is indicated in dogs for the treatment of the following conditions: - Dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as staphylococci, E. coli and Proteus mirabilis
POSEBNA OPOZORILA 
SPECIAL WARNING(S)
Pri mačkah so občutljivi mikroorganizmi E. coli, Staphylococcus spp., 
In cats, relevant susceptible micro-organisms are E.coli, Staphylococcus spp., Pasteurella spp., Proteus spp.
in druge oblike interakcij Fluorokinolonov ne smemo uporabljati v kombinaciji z nesteroidnimi protivnetnimi zdravili (NSAID) pri psih, ki imajo v anamnezi konvulzije. 
Fluoroquinolones should not be used in combination with non-steroidal anti-inflammatory drugs (NSAIDs) in dogs with a history of seizures.
Ibaflin 30 mg: ibafloksacin 30 mg Ibaflin 150 mg: 
Ibaflin 30 mg Ibaflin 150 mg
Ime in naslov imetnika dovoljenja za izdelavo zdravila, odgovornega za sprostitev serije Intervet GesmbH. 
Name and address of the Manufacturing Authorisation Holder responsible for batch release
ZLOŽENKA 
Lactose
MIK 
Starch
Ibaflin gel uporabljamo na podlagi izvidov testiranja občutljivosti povzročitelja. 
Ibaflin gel should be used based on susceptibility testing.
Indikacije za uporabo Ibaflin gel je pri psih indiciran za zdravljenje naslednjih bolezenskih stanj: 
Ibaflin gel is indicated in dogs for the treatment of the following conditions:
NAVEDBA NAJVIŠJIH DOVOLJENIH KOLIČIN OSTANKOV ZDRAVILA (MRL) 
QUANTITY OF THE ACTIVE SUBSTANCE(S)
s 100 tabletami v zavarjenih pretisnih omotih iz pvc in aluminija - zloženka z 10, 20 ali 
- Carton box with 20 or 100 tablets in PVC/aluminium heat sealed blisters 150 mg tablets: - Carton box with 10, 20 or 100 tablets in PVC/aluminium heat sealed blisters - Carton box with 10, 20 or 100 tablets in PVC/PVDC/aluminium blisters
Peroralno, 15 mg ibafloksacina/kg, 1-krat na dan 15 mg/kg telesne mase = 1 ml gela/5 kg telesne mase 
15 mg per kg bodyweight = 1 ml of gel per 5 kg bodyweight
- dermalne okužbe (okužbe mehkega tkiva - rane, abscesi), ki jih povzročajo občutljivi mikroorganizmi, kot so Staphylococcus spp., E. coli, Proteus spp. 
- Dermal infections (soft tissue infections - wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp, E. coli, Proteus spp.
Okužbe dihalnih poti (zgornjih dihal), ki jih povzročajo občutljivi sevi stafilokokov, E. coli in 
Respiratory tract infections (upper tract) caused by susceptible strains of Staphylococci, E. coli, and Klebsiella spp.
BESEDILO “ZDRAVILO SHRANJUJTE NEDOSEGLJIVO OTROKOM ” Zdravilo shranjujte nedosegljivo otrokom. 
THE WORDS "KEEP OUT OF THE REACH AND SIGHT OF CHILDREN" Keep out of the reach and sight of children.
1 nastavljiva, napolnjena večodmerna brizga 
1 adjustable pre-filled multidose syringe, containing 15 ml.
Zdravila ne uporabljajte v kombinaciji z nesteroidnimi protivnetnimi zdravili (NSAID) pri psih, ki imajo v anamnezi krče. 
Do not use in combination with nonsteroidal anti-inflammatory drugs (NSAIDs) in dogs with a history of seizures.
Ena tableta Ibaflina vsebuje: 
QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet of Ibaflin contains:
POT(I) UPORABE ZDRAVILA Peroralno 15 mg/kg telesne mase, 1-krat na dan. 
ROUTE(S) OF ADMINISTRATION Oral use, 15 mg per kg bodyweight once daily.
tableti 300 mg ibafloksacina v 1 tableti 900 mg ibafloksacina v 1 tableti 
30 mg of ibafloxacin per tablet 150 mg of ibafloxacin per tablet 300 mg of ibafloxacin per tablet 900 mg of ibafloxacin per tablet
Peroralno, 15 mg ibafloksacina/kg telesne mase, 1-krat na dan. 
Oral use, 15 mg ibafloxacin/kg bodyweight once daily.
Ne uporabite pri psih, ki so lažji od 3 kg. 
Do not use in dogs with a weight of less than 3 kg. Ibaflin should only be used based on susceptibility testing.
Ibaflin gel lahko dajemo brejim psicam. 
Ibaflin gel can be used during pregnancy in dogs.
Študije varnosti za ciljno živalsko vrsto, izvedene pri psih, pasme beagle, starih 8 mesecev, so pokazale, da ibafloksacin po peroralnem dajanju v odmerkih po 45 mg/kg telesne mase na dan 
Target animal safety studies in beagle dogs of 8 months of age demonstrated that, when administered orally at 45 mg/kg/day (three times the recommended dose) for a period of 90 days, ibafloxacin produced no observable adverse effects.
Z AUPORABO V VETERINARSKI MEDICINI Ibaflin 7,5 %, peroralni gel 
NAME OF THE VETERINARY MEDICINAL PRODUCT Ibaflin 7.5% oral gel
UČINKI Driska, mehko blato, bruhanje, otopelost in anoreksija se pojavljajo redko. Ti učinki so bili blagi in prehodni. 
Diarrhoea, soft faeces, vomiting, dullness, anorexia and salivation were observed with low frequency.
Peroralno, 15 mg ibafloksacina/kg, 1-krat na dan 15 mg /kg telesne mase = 0,5 ml gela/kg telesne mase 
15 mg per kg bodyweight = 0.5 ml of gel per kg bodyweight
OVOJNINAH 
Yeast
UPORABO ZA BRIZGE S PERORALNIM GELOM 7,5 % 
PACKAGE INSERT FOR INCLUSION WITH THE 7.5 % ORAL GEL SYRINGE PACKAGES
0,5 ml gela/kg telesne mase) Pred uporabo preberite navodilo za uporabo. 
15 mg per kg bodyweight = 0.5 ml of gel per kg bodyweight Read the package insert before use.
ŠTEVILKA SERIJE 
MANUFACTURER'S BATCH NUMBER
Peroralno, 15 mg/kg telesne mase, 1-krat na dan 15 mg/kg telesne mase = 1 ml gela/5 kg telesne mase Pred uporabo preberite navodilo za uporabo. 
15 mg per kg bodyweight = 1 ml of gel per 5 kg bodyweight Read the package insert before use.
NASTAVLJIVA VEČODMERNA BRIZGA IBAFLIN 7,5 % PERORALNEGA GELA 
IBAFLIN 7.5% ORAL GEL ADJUSTABLE MULTIDOSE SYRINGE
- dermalne okužbe (pioderma - površinska in globoka, rane, abscesi), ki jih povzročajo občutljivi mikroorganizmi, kot so Staphylococcus spp., E. coli in Proteus mirabilis 
- Dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp., E. coli and Proteus mirabilis.
NASTAVLJIVA VEČODMERNA BRIZGA IBAFLIN 3 %, PERORALNI GEL 
IBAFLIN 3% ORAL GEL ADJUSTABLE MULTIDOSE SYRINGE
IZDELOVALČEVA 
Excipients
Ibaflin gel je pri mačkah indiciran za zdravljenje naslednjih bolezenskih stanj: - dermalne okužbe (okužbe mehkega tkiva - rane, abscesi), ki jih povzročajo občutljivi mikroorganizmi, kot so Staphylococcus spp., E. coli, Proteus spp. 
INDICATIONS Ibaflin gel is indicated in dogs for the treatment of the following conditions: - Dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp., E. coli and Proteus mirabilis.
Gel dajemo ob času hranjenja. 
The gel should be administered at the time of feeding.
4.9 Odmerjanje in pot uporabe Peroralno, 15 mg ibafloksacina/kg 1-krat na dan. 
METHOD AND ROUTE(S) OF ADMINISTRATION Oral use, 15 mg per kg bodyweight once daily.
Enterobacter spp., E. coli in Klebsiella spp. 
coli, Klebsiella spp.
Dermalne okužbe (pioderma - površinska in globoka, rane, abscesi), ki jih povzročajo občutljivi sevi stafilokokov, E. coli in Proteus mirabilis 
Dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains such as Staphylococci, E. coli, Proteus mirabilis.
75 mg ibafloksacina v 1 ml gela 
QUANTITY OF THE ACTIVE SUBSTANCE(S) 75 mg of ibafloxacin per ml of gel
Osebe z znano preobčutljivostjo za kinolone naj se izogibajo stiku z zdravilom. 
Special precautions to be taken by the person administering the product Persons with known hypersensitivity to quinolones should avoid contact with the veterinary medicinal product.
ZA PROMET EU/2/00/022/11 
MARKETING AUTHORISATION NUMBER(S) EU/2/00/022/11
s pomikom objemke na ustrezno mesto na batu (brizga 
The syringe should be adjusted to the calculated dosage by setting the ring on the appropriate place on the plunger (steps of 0.5 ml for the 15 ml syringe).
NAVODILO ZA 
mg. administered
Zato ibafloksacina ne smemo dajati mačkam, mlajšim od 8 mesecev. Pri psih je obdobje rasti pri različnih pasmah različno. 
Therefore, ibafloxacin should not be used in cats aged less than 8 months.
ZA PROMET EU/2/00/022/09 
MARKETING AUTHORISATION NUMBER(S) EU/2/00/022/09
Akutne, nezapletene okužbe sečil, ki jih povzročajo občutljivi sevi stafilokokov, Proteus spp., 
Acute, uncomplicated urinary tract infections, caused by susceptible strains of Staphylococci, Proteus spp., Enterobacter spp., E. coli and Klebsiella spp.
ibafloksacin 300 mg Ibaflin 900 mg: ibafloksacin 900 mg 
Ibafloxacin 900 mg
Това изисква 30-60 секунди, за да бъде ефективно. 
It requires 30-60 seconds to be effective.
Въпреки всичко рискът не може да бъде изключен напълно. 
However, a risk cannot be completely excluded.
9) Инжектирането продължава максимум 10 секунди. 
9) The injection lasts for a maximum of 10 seconds.
Не го използвайте, ако датата е минала. 
Do not use if the date has passed.
Тези мерки ще помогнат за опазването на околната среда. 
These measures will help protect the environment.
Трябва да видите зелена пластмаса. 
You should see green plastic.
Честотата на тези рискове при деца не е известна. 
The frequency of these risks in children is not known.
Може също да бъдат направени допълнителни изследвания по време на и след лечението. 
Further tests may also be done during and after treatment.
Ще получите съответното обучение как да правите това. 
You will receive appropriate training for you to do this.
Ако се чувствате изморени или замаяни, не трябва да шофирате или да използвате машини. 
If you feel tired or dizzy, you should not drive or use machines.
Пикови плазмени концентрации се постигат в рамките на 1-2 часа. 
Plasma peak concentrations are attained within 1-2 hours.
Вие и Вашият лекар можете да вземете решение относно подходящ ден всяка седмица, когато да получавате Вашата инжекция. 
You and your doctor can decide on a suitable day each week to receive your injection.
Ще почувствате и чуете второ „щракване” в момента в който инжектирането е приключило. 
You will feel and hear a second “click” once the injection is completed.
Медицинските специалисти и пациентите трябва да бъдат ясно инструктирани. 
Healthcare professionals and patients should be clearly instructed.
2132 WT Hoofddorp Нидерландия 
2132 WT Hoofddorp The Netherlands
Препоръчва се да се уточни определен ден от седмицата като „ден за инжекция”. 
It is recommended to specify a certain day of the week as “day for injection”.
Изчакайте 2-3 секунди преди да отстраните писалката от кожата си. 
10) Wait another 2-3 seconds before removing the pen from your skin.
*Арбитражна EMEA/H/A-31/1463 
*Referral EMEA/H/A-31/1463
Не използвайте Nordimet по време на бременност или ако се опитвате да забременеете. 
Do not use Nordimet during pregnancy or if you are trying to become pregnant.
Тази дата се отнася за последния ден от този месец. 
The expiry date refers to the last day of that month.
Попитайте Вашия фармацевт как да изхвърлите лекарствата които вече не използвате. 
Ask your pharmacist how to throw away medicines you no longer use.
Съобщаването на подозирани нежелани реакции след разрешението за употреба на лекарствения продукт е важно. 
Reporting suspected adverse reactions after authorisation of the medicinal product is important.
Някои пациенти не показват признаци на предозиране. 
Some patients showed no signs of overdose.
Винаги използвайте това лекарство точно по начина, който Ви е казал 
Always use this medicine exactly as your doctor has told you.
Nordimet с храна, напитки и алкохол 
Nordimet with food, drink and alcohol
Не пропускайте назначените кръвни изследвания. 
Do not miss appointments for blood tests.
Средният терминален полуживот е 6-7 часа и показва значителни вариации (3-17 часа). 
Average terminal half-life is 6-7 hours and demonstrates considerable variation (3-17 hours).
Не променяйте дозата без препоръка от Вашия лекар. 
Do not change the dose without your doctor's recommendation.
SE-201 25 Malmo Швеция 
SE-201 25 Malmo Sweden
При липса на проучвания за несъвместимости, това лекарствен продукт не трябва да се смесва с други лекарствени продукти. 
In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
В зависимост от индивидуалната активност на заболяването и поносимост на пациента, началната доза може да бъде увеличена. 
Depending on the individual activity of the disease and patient tolerability, the initial dose may be increased.
Това означава, че цялата течност е била инжектирана. 
This means that all the fluid has been injected.
Важно е да информирате своя лекар, че приемате Nordimet. 
It is important to tell your doctor that you are taking Nordimet.
Седнете или легнете в отпусната, удобна поза. 
2) Sit or lie in a relaxed, comfortable position.
Особено пациентите в старческа възраст трябва да бъдат преглеждани за ранни признаци на токсичност през кратки интервали. 
Particularly elderly patients should be examined for early signs of toxicity in short intervals.
Като всички лекарства, това лекарство може да причини нежелани реакции, въпреки че не всеки ги получава. 
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Вашият лекар обаче може да реши, че можете да се научите да си инжектирате Nordimet сами. 
However, your doctor may decide that you can learn how to inject Nordimet yourself.
Други лекарства и Nordimet 
Other medicines and Nordimet
Ако това не е така, използвайте друга писалка. 
If not, use another pen.
Въпреки това, понеже тежки нежелани реакции могат да се появят дори при ниски дози, належащо е пациентите да бъдат редовно наблюдавани от лекар през кратки интервали. 
However, as severe undesirable effects can occur even at lower doses, it is indispensable that patients are monitored regularly by the doctor at short intervals.
ATC код: L04AX03 
ATC code: L04AX03
Изследванията по-долу трябва да бъдат извършвани всяка седмица през първите две седмици, след това на всеки две седмици през следващия месец; след този период, в зависимост от броя на левкоцитите и стабилността на пациента, поне веднъж месечно през следващите шест месеца и поне на всеки три месеца впоследствие. 
The tests below must be conducted every week during the first two weeks, then every two weeks for the next month; afterwards, depending on leukocyte count and stability of the patient, at least once monthly during the next six months and at least every three months thereafter.
Лекарят ще изчисли необходимата доза според телесната повърхност на детето (m2), а дозата се изразява като mg/m 
The doctor will calculate the dose required from the child's body surface area (m2), and the dose is expressed as mg/m
В началото на Вашето лечение Nordimet може да бъде инжектиран от медицински специалист. 
At the start of your treatment, Nordimet may be injected by medical staff.
Безопасността и ефикасността на Nordimet при деца под 3-годишна възраст не са установени (вж. точка 4.4). 
The safety and efficacy of Nordimet in children < 3 years of age have not been established (see section 4.4).
Лекарят може да увеличи дозата, ако използваната не е ефективна, но се понася добре. 
The doctor may increase the dose if the used dose is not effective but tolerated well.
Съобщете на Вашия лекар или фармацевт, ако приемате, приемали сте или може да приемете други лекарства, включително лекарства получавани без рецепта, както и билкови и естествени медицински продукти. 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription and herbal or natural medicinal products.
Да се използва само веднъж седмично 
Use only once a week
Тази листовка беше последно преразгледана през 
This leaflet was last revised in
Това ще вкара лекарството под кожата. 
This will send the medication under the skin.
Времени увеличения на трансаминазите до два или три пъти над горната граница на нормата се съобщават при пациенти при честота 13-20%. 
Temporary increases in transaminases to two or three times the upper limit of normal have been reported in patients at a frequency of 13-20 %.
Поради риска от тежки или дори летални токсични реакции, пациентите трябва да бъдат изчерпателно информирани от лекарите относно рисковете (включително ранните признаци и симптоми на токсичност) и препоръчителните мерки за безопасност. 
Due to the risk of severe or even fatal toxic reactions, patients should be thoroughly informed by the doctor about the risks (including early signs and symptoms of toxicity) and recommended safety measures.